<DOC>
	<DOCNO>NCT01496690</DOCNO>
	<brief_summary>The PACS study aim investigate efficacy tolerability pregabalin schizophrenic patient suffer comorbid anxiety . The study design 8 week flexible dosage , randomize placebo control . The study population patient diagnose ICD-10 schizophrenia age 18-65 . Patients recruit outpatient clinic entire Denmark .</brief_summary>
	<brief_title>Pregablin Anxiety-comorbidity Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Ages 1865 year An ICD10 schizophrenia diagnosis F20.020.3 F20.9 Stable dosage psychotropic 4 week inclusion Hamilton Anxiety Scale total score &gt; 15 Positive Negative Syndrome Scale Schizophrenia total score &lt; 70 The Calgary Depression Scale Schizophrenia total score &lt; 10 Fertile woman : Contraception trial Screatinin within normal reference range Signed informed consent power attorney Significant substance abuse QTc &gt; 480 millisecond Severe dysregulated diabetes For woman : Pregnancy breastfeed Confinement accordance Danish Law Psychiatry Concrete suicidally Known hypersensitivity allergic reaction active ingredient drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Anxiety-comorbidity schizophrenia</keyword>
	<keyword>Double-blinded randomize placebo control trial</keyword>
	<keyword>Pregabalin</keyword>
</DOC>